Polydatin as a natural ClpP modulator for combating methicillin-resistant Staphylococcus aureus infection
Frontiers in Cellular and Infection Microbiology · 2026
DOI: 10.3389/fcimb.2026.1744317 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Ying Qin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, First Hospital of Jilin University, Changchun, China. Hauptthemen laut MEDLINE: Glucosides, Methicillin-Resistant Staphylococcus aureus, Stilbenes, Anti-Bacterial Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Methicillin resistant Staphylococcus aureus , MRSA, is a major cause of hospital acquired infections and poses a serious therapeutic challenge because of multidrug resistance and potent virulence. Targeting virulence rather than bacterial growth may provide an alternative strategy to combat MRSA infection. This study investigated polydatin, a stilbenoid glucoside from Polygonum cuspidatum , as a potential antivirulence agent targeting caseinolytic protease P, ClpP.
Methods
ClpP inhibitory activity was evaluated by enzymatic assay. The effects of polydatin on bacterial growth, hemolytic activity, virulence gene expression, adhesion to fibrinogen, and host cell invasion were assessed in vitro . Target engagement was examined by thermal shift assay, fluorescence quenching, and computational simulation. Therapeutic efficacy was evaluated in a murine pneumonia model.
Results
Polydatin showed limited antibacterial activity but significantly inhibited ClpP and reduced the expression of key virulence factors, including Hla, PVL, and RNAIII. It also impaired bacterial adhesion to fibrinogen and invasion of host cells. Binding studies supported the interaction between polydatin and ClpP. In vivo , polydatin markedly alleviated S. aureus induced pneumonia, as shown by reduced lung bacterial burden, lower inflammatory cytokine levels, and attenuated tissue injury.
Discussion
Polydatin attenuates MRSA pathogenicity by targeting ClpP associated virulence regulation rather than bacterial viability. These findings identify polydatin as a promising antivirulence candidate and provide a basis for developing alternative therapeutic strategies against MRSA infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, First Hospital of Jilin University, Changchun, China.
- College of Animal Science, Jilin University, Changchun, China.
- Department of Pharmacology, College of Basic Medical Sciences, Jilin University, Changchun, China.
Zitieren
APA
Qin, Y., Yang, J., Wang, G., Yang, L., Wang, D., & Luan, Y. (2026). Polydatin as a natural ClpP modulator for combating methicillin-resistant Staphylococcus aureus infection. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2026.1744317
Vancouver
Qin Y, Yang J, Wang G, Yang L, Wang D, Luan Y. Polydatin as a natural ClpP modulator for combating methicillin-resistant Staphylococcus aureus infection. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2026.1744317
BibTeX
@article{Qin2026,
author = {Qin, Ying and Yang, Jingjing and Wang, Guangming and Yang, Luna and Wang, Dacheng and Luan, Yongxin},
title = {Polydatin as a natural ClpP modulator for combating methicillin-resistant Staphylococcus aureus infection},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
doi = {10.3389/fcimb.2026.1744317}
}
EUVIMED